Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 451-500 of 6028 result(s).
CYDY CytoDyn Inc
10/14/2024 1:32:52 AM
Also Ken, I think FcRn & Latch base (13)
CYDY CytoDyn Inc
10/14/2024 1:26:59 AM
Six degrees of Kevin Bacon is not a (7)
CYDY CytoDyn Inc
10/11/2024 2:28:28 AM
The fact that his steroid regimen i (17)
CYDY CytoDyn Inc
10/10/2024 2:50:38 AM
“No rebound, cell-associated vira (13)
CYDY CytoDyn Inc
10/09/2024 9:52:12 AM
Good article……Inflammation ever (3)
CYDY CytoDyn Inc
10/09/2024 7:37:16 AM
p53 (upregulated by leronlimab) can (6)
CYDY CytoDyn Inc
10/09/2024 7:11:42 AM
Merck’s $1.9 billion deal for res (25)
CYDY CytoDyn Inc
10/08/2024 3:27:01 PM
I just wonder what happens when an (11)
CYDY CytoDyn Inc
10/08/2024 3:21:16 PM
Dr. Chaffee's video offering an alt (4)
CYDY CytoDyn Inc
10/08/2024 3:03:47 PM
So if TAS is knocking out neutrophi (6)
CYDY CytoDyn Inc
10/08/2024 2:42:40 PM
inflammaging? Is this on Ohm's list (7)
CYDY CytoDyn Inc
10/07/2024 1:44:55 PM
Just goes to show that a small phas (20)
CYDY CytoDyn Inc
10/07/2024 1:37:47 PM
just curious if bevacizumab was he (10)
CYDY CytoDyn Inc
10/07/2024 12:57:58 PM
A phase 2 refractory CRC trial with (9)
CYDY CytoDyn Inc
10/07/2024 2:41:56 AM
why only 5 in the LL-only?? What do (21)
CYDY CytoDyn Inc
10/06/2024 4:22:19 AM
Hi OHM, could you please speak to t (21)
CYDY CytoDyn Inc
10/05/2024 2:20:24 AM
why do I suddenly feel... that four (4)
CYDY CytoDyn Inc
10/05/2024 2:14:33 AM
I wish this were so, HHi, but if I (14)
CYDY CytoDyn Inc
10/05/2024 2:03:09 AM
It looks like Leronlimab will compl (25)
CYDY CytoDyn Inc
10/02/2024 3:32:36 PM
It's absolutely an impediment to ra (33)
CYDY CytoDyn Inc
10/02/2024 3:12:46 PM
Perhaps now there’s a Covid paper (4)
CYDY CytoDyn Inc
10/02/2024 12:58:11 AM
Interesting mouse study in Glioblas (24)
CYDY CytoDyn Inc
10/01/2024 11:56:44 PM
I'm a little shocked at the massive (10)
CYDY CytoDyn Inc
10/01/2024 11:54:02 PM
That just means that shares that we (10)
CYDY CytoDyn Inc
10/01/2024 11:48:16 PM
Only 1.7 million shares traded. By (5)
CYDY CytoDyn Inc
09/30/2024 7:25:49 PM
It will probably become the equival (6)
CYDY CytoDyn Inc
09/28/2024 4:17:22 AM
It has come to my attention coming (19)
CYDY CytoDyn Inc
09/28/2024 3:52:28 AM
Probably already brought up by some (17)
CYDY CytoDyn Inc
09/28/2024 3:36:08 AM
Does Leronlimab-PLS start the paten (11)
CYDY CytoDyn Inc
09/28/2024 3:28:47 AM
Good thing cydy has a future blockb (17)
CYDY CytoDyn Inc
09/28/2024 3:17:37 AM
Shorts made a killing and are looki (20)
CYDY CytoDyn Inc
09/28/2024 3:01:55 AM
Pegozafermin and Leronlimab look to (10)
CYDY CytoDyn Inc
09/27/2024 2:38:57 PM
Cyder tries again - lol, don;t forg (17)
CYDY CytoDyn Inc
09/27/2024 2:32:29 PM
doesn't look like a drug I'd want t (10)
CYDY CytoDyn Inc
09/27/2024 2:29:45 PM
a recent Emory University study sho (13)
CYDY CytoDyn Inc
09/25/2024 6:54:49 PM
The scalawag (Cyder) just won't sto (26)
CYDY CytoDyn Inc
09/25/2024 6:04:37 PM
IF,...the Federal Government wants (19)
CYDY CytoDyn Inc
09/25/2024 5:43:46 PM
OK,... so given the fact that it is (15)
CYDY CytoDyn Inc
09/25/2024 5:34:56 PM
It looks like there is a better PD- (13)
CYDY CytoDyn Inc
09/25/2024 5:12:34 PM
Should we not be going after CRP as (19)
CYDY CytoDyn Inc
09/25/2024 9:51:57 AM
However, can leronlimab serve to mi (17)
CYDY CytoDyn Inc
09/25/2024 6:55:45 AM
So my request is to explain the eff (14)
CYDY CytoDyn Inc
09/25/2024 6:08:29 AM
Lanifibranor received BTD for these (7)
CYDY CytoDyn Inc
09/25/2024 5:51:45 AM
a fellow Irishman..who has spent hi (5)
CYDY CytoDyn Inc
09/25/2024 5:43:23 AM
14% reduction in placebo group? The (11)
CYDY CytoDyn Inc
09/25/2024 5:35:22 AM
"Fibrosis improvement by at least o (20)
CYDY CytoDyn Inc
09/25/2024 4:58:08 AM
ALWAYS someone...looking for the cl (9)
CYDY CytoDyn Inc
09/25/2024 4:54:45 AM
Can’t Wait to see what the impact (18)
CYDY CytoDyn Inc
09/25/2024 4:32:05 AM
They used the word “appears” be (24)
CYDY CytoDyn Inc
09/24/2024 3:34:48 PM
Interestingly, what is not reported (21)
Go to page:
  • << First
  • < Previous
  • 9
  • 10
  • Next >

Recent Articles

  • RFK Jr. Denies 2028 Candidacy Amid MAGA Leadership Tensions
  • Trump's Assurance from Xi Jinping on Taiwan's Security
  • Sam Altman: OpenAI's Public Offering and Future Investments
  • Air Canada Flight Operations Halted Amidst Flight Attendants Strike
  • Northwest Registered Agent: Leading All-in-One Startup Resource
  • Concerns Grow as Tesla Executive Sells Huge Portion of Shares
  • Faraday Future's Livestream Event for Strategic Initiatives
  • Faraday Future Announces Major Strategy Upgrade Livestream Details
  • Unlocking Your E-Commerce Dreams with Proper Ecom's Program
  • Social Security's Urgent Future: Navigating Potential Benefit Cuts
  • Chamath Palihapitiya Challenges College Norms in Today’s Economy
  • Join the SelectQuote Class Action: Protect Your Investment Now
  • Class Action Lawsuit Against KinderCare: Key Details for Investors
  • Investigation of Apple Inc. by Kahn Swick & Foti LLC Revealed
  • Explore SETT NOIR: A Stellar Sterling Silver Jewelry Line
  • Neogen Corporation Faces Class Action: Key Information for Investors
  • Investors Alert: Important Updates on Hims & Hers Health Cases
  • Key Developments in Flywire Corporation's Shareholder Lawsuit
  • Investors Alert: Lead Plaintiff Deadline in SOC Class Action
  • Justice for Noe Rodriguez: Press Conference Highlights
  • Trump Administration's Week 30: Achievements and Announcements
  • Trump and Putin's Recent Summit: Hopes and Challenges Ahead
  • Kokomo Solutions Investigated for Student Data Security Breach
  • America’s Resurgence: The Highlights of Week 30 Under Trump
  • Exploring OpenAI's Partnership with Federal Agencies for AI Access
  • Anniversary Celebration: DermRays Unveils New Laser Innovations
  • DermRays Marks a Milestone with a New Laser Device Launch
  • Prime Drink Group Updates on MCTO and Successful Fundraising
  • A.I.S. Resources Updates on Default Status and Progress Report
  • Investors Unite: Opportunities from Charter Communications' Case
  • Investors Explore Legal Action Against Fiserv, Inc. for Fraud
  • Western Asset Mutual Fund Investors Can Take Legal Action Now
  • Grand Canyon University's Legal Victory Marks a New Chapter
  • HF Sinclair Finalizes Tender Offer and Debt Securities Update
  • Transforming $100 into $452: The Texas Roadhouse Journey
  • Rocket Companies Provides Insights on Exchange Offers and Consents
  • Rocket Companies Tenders for Nationstar Mortgage Bonds
  • Transforming Car Purchases: Cryptocurrency and Luxury Vehicles
  • Transforming $1000 in US Foods Holdings into Wealth Over Time
  • Celebrating Two Decades of Innovation with Five Star Solutions
  • Novelis' Tender Offer Results for Senior Notes Announced
  • RYVYL Transitions Leadership as It Enhances Crypto Focus
  • How a $100 Investment in UMB Financial Has Grown Over Time
  • The Incredible Growth of Baidu: A 20-Year Investment Journey
  • Sky Quarry Inc. Reports Impressive Growth in Q2 Financials
  • Orthodox Jewish Community Protests Israeli Draft Policies
  • Sky Quarry's Latest Financial Performance Indicates Growth Potential
  • IronOrbit Celebrates Three Years in Gartner Magic Quadrant
  • The Surprising Growth of Ciena: A 15-Year Journey
  • NorthStrive Companies Inc. Celebrates Two Major Acquisitions
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site